Kintegral Advisory LLC Has $9.67 Million Position in Procter & Gamble Company (The) $PG

Kintegral Advisory LLC lessened its holdings in Procter & Gamble Company (The) (NYSE:PG) by 0.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 60,677 shares of the company’s stock after selling 91 shares during the quarter. Procter & Gamble comprises about 0.9% of Kintegral Advisory LLC’s investment portfolio, making the stock its 21st largest position. Kintegral Advisory LLC’s holdings in Procter & Gamble were worth $9,667,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Procter & Gamble during the 1st quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its stake in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its position in Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.4%

NYSE:PG opened at $147.54 on Tuesday. The company’s 50 day moving average is $155.18 and its 200-day moving average is $159.27. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43. The firm has a market cap of $345.32 billion, a price-to-earnings ratio of 22.66, a P/E/G ratio of 3.97 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble’s revenue was up 1.7% compared to the same quarter last year. During the same period last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the transaction, the insider directly owned 12,616 shares of the company’s stock, valued at $1,920,533.68. The trade was a 3.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 in the last quarter. Insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Bank of America reduced their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $172.21.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.